Li Haijun is the founder of Raynovent. Raynovent has raised $54M in total funding. Latest round: Series C. Backed by Efung Capital, Yide Fund.
Haijun Li is a co-founder of Raynovent, a biotech company established in October 2018. Based in Guangzhou, China, Raynovent specializes in developing and commercializing innovative therapies for respiratory and metabolic diseases, including treatments for influenza, COVID-19, and NASH. The company has raised $53.6 million in funding.
Full founder directory · Investor directory · Company funding database · Fundraising library